Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Shareholders??? Equity (Details)

v3.26.1
Shareholders’ Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Jan. 26, 2026
Jan. 07, 2025
Nov. 04, 2024
Jun. 30, 2023
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2016
Jan. 22, 2026
Sep. 30, 2025
Jan. 06, 2025
Dec. 18, 2024
Sep. 30, 2024
Aug. 31, 2021
Shareholders’ Equity [Line Items]                            
Net of issuance costs (in Dollars)         $ 30,758 $ 13,787 $ 22,496              
Authorized ordinary shares         200,000,000 165,000,000       200,000,000        
Warrants consideration value (in Dollars)         $ 12 $ 428                
Plan expiration period               7 years            
Percentage of ordinary shares outstanding         5.00%                  
Expected dividend yield         0.00% 0.00% 0.00%              
Stock-based compensation (in Dollars)         $ 664 $ 1,186 $ 629              
Tranche A Warrants [Member]                            
Shareholders’ Equity [Line Items]                            
Sold per unit (in Dollars per share)     $ 2.35                      
Sale of ordinary shares     8,250,000                      
Pre-funded warrants     1                      
Warrant to purchase of ordinary shares     1                      
Warrants exercised shares                     118,134      
Warrants consideration value (in Dollars)                     $ 278      
Tranche B Warrants [Member]                            
Shareholders’ Equity [Line Items]                            
Sold per unit (in Dollars per share)     $ 1.82                      
Sale of ordinary shares     8,250,000                      
Pre-funded warrants     1                      
Warrant to purchase of ordinary shares     1                      
Warrants exercised shares                     118,134      
Warrants consideration value (in Dollars)                     $ 215      
Two Thousand Sixteen Incentive Plan [Member]                            
Shareholders’ Equity [Line Items]                            
Plan expiration period           10 years                
Options vested period               4 years            
2021 Plan [Member]                            
Shareholders’ Equity [Line Items]                            
Additional reserved ordinary shares                       3,698,746    
2021 Plan [Member]                            
Shareholders’ Equity [Line Items]                            
Ordinary shares were reserved for issuance                           4,079,427
Options vested period         4 years                  
Percentage of ordinary shares outstanding                           5.00%
Additional reserved ordinary shares           4,230,715                
Vesting period, description         The vesting period of the awards is generally four years. Generally, under the terms of the Plans, unless determined otherwise, 25% of an award granted becomes exercisable on the first anniversary of the date of grant and 6.25% becomes exercisable once every quarter during the subsequent three years.                  
Common Stock [Member]                            
Shareholders’ Equity [Line Items]                            
Ordinary shares issue value (in Dollars)       $ 23,000                    
Ordinary shares issue       11,794,873                    
Purchase price (in Dollars per share)       $ 1.95                    
Net of issuance costs (in Dollars)       $ 22,496                    
Authorized ordinary shares                         165,000,000  
Ordinary share issued         10,332,031 4,293,957 11,794,873              
Warrants exercised shares             106,414              
Additional reserved ordinary shares         5,511,500                  
Common Stock [Member] | Pre-Funded Warrant [Member]                            
Shareholders’ Equity [Line Items]                            
Warrants to purchase     3,956,043                      
Common Stock [Member] | Tranche A Warrants [Member]                            
Shareholders’ Equity [Line Items]                            
Warrants exercised shares                     118,134      
Common Stock [Member] | Tranche B Warrants [Member]                            
Shareholders’ Equity [Line Items]                            
Warrants exercised shares                     118,134      
Common Stock [Member] | 2021 Plan [Member]                            
Shareholders’ Equity [Line Items]                            
Percentage of ordinary shares outstanding           4.00%                
Common Stock [Member] | Two Thousand Sixteen Incentive Plan [Member]                            
Shareholders’ Equity [Line Items]                            
Ordinary shares were reserved for issuance               3,384,454            
Subsequent Event [Member]                            
Shareholders’ Equity [Line Items]                            
Gross proceeds offering cost (in Dollars) $ 18,500                          
Subsequent Event [Member] | Common Stock [Member]                            
Shareholders’ Equity [Line Items]                            
Gross proceeds offering cost (in Dollars) $ 18,500                          
Sold per unit (in Dollars per share) $ 1.4                          
Sale of ordinary shares 13,225,000                          
Additional reserved ordinary shares                 3,534,973          
Public Offering [Member]                            
Shareholders’ Equity [Line Items]                            
Gross proceeds offering cost (in Dollars)     $ 15,000                      
Offering expenses (in Dollars)     $ 1,200                      
Sold per unit (in Dollars per share)     $ 1.82                      
Ordinary share issued     1                      
Public Offering [Member] | Pre-Funded Warrant [Member]                            
Shareholders’ Equity [Line Items]                            
Warrants to purchase     1                      
Lieu amount of ordinary share     1                      
Public Offering [Member] | Tranche A Warrants [Member]                            
Shareholders’ Equity [Line Items]                            
Warrants to purchase     1                      
Public Offering [Member] | Tranche B Warrants [Member]                            
Shareholders’ Equity [Line Items]                            
Warrants to purchase     1                      
IPO [Member] | Common Stock [Member]                            
Shareholders’ Equity [Line Items]                            
Underwritten public offering     4,293,957                      
Direct Public Offering [Member]                            
Shareholders’ Equity [Line Items]                            
Gross proceeds offering cost (in Dollars)   $ 33,100                        
Sale of ordinary shares   10,332,031                        
Direct Public Offering [Member] | Common Stock [Member]                            
Shareholders’ Equity [Line Items]                            
Gross proceeds offering cost (in Dollars)   $ 30,800